Merck 1st-Quarter Profit Jumps 12 Pct.
Join the discussion below, or Read more at Bucks County Courier Times.
#1 Apr 30, 2007
#4 Sep 20, 2012
Merck has a line of various drug treatments that may have contributed greatly to their sales, it may be no surprise that their profits will skyrocket by leaps and bounds by the end of the year. As the initial developer and innovator of Fosamax, the first bone loss drug, one can only imagine how the pioneering antiresorptive medication may have impacted the pharmaceutical firm in sales. However, as Merck has been gaining, many patients have also been reported to be experiencing losses in health. Visit http://www.fosamax-lawsuit.net for additional for comprehensive and current information.
#5 Feb 8, 2013
In 2004, the Food and Drug Administration reviewed the safety of bisphosphonates and concluded that osteonecrosis of the jaw could be a risk for the class of drugs as a whole, not just those that are administered intravenously. The agency asked manufacturers to amend drug labels to acknowledge that there have been reports of jawbone death in patients taking the drugs. If you want to know more about bone health and related injuries, visit http://www.fosamaxinjurylawsuitcenter.com/cla... for more information.
Add your comments below
|After Trump rally, equity investors move into h...||Mar 24||Retribution||6|
|Bristol Palin says abstinence best path for teens (May '09)||Mar 23||Dakoter||2,656|
|N/R: Lack of mental, epileptic drugs hit health...||Mar 8||Humanspirit||1|
|The EpiPen debacle may be the shot heard around...||Feb 25||Suezanne||2|
|Despite $19 million salary, Mylan CEO failed to... (Sep '16)||Feb 25||Suezanne||3|
|Myriad Genetics Announces an Assay that Identif...||Feb '17||Purplemouse2||8|
|Kane receives bad rap from business owner (Oct '09)||Feb '17||Fed up resident||7|
Find what you want!
Search Biotech Forum Now
Copyright © 2017 Topix LLC